Uses of Amypira

Amypira medicine has the main active ingredient Piracetam and other excipients in a sufficient amount. This is a drug belonging to the group of psychotropic drugs used in the treatment of symptoms of dizziness, memory impairment, ...

Amypira medicine has the main active ingredient Piracetam and other excipients in a sufficient amount. This drug belongs to the group of psychotropic drugs. Packing is a box of 2 blisters, each blister contains 5 ampoules of 5ml. Amypira is a psychotropic drug that is used in the treatment of symptoms of dizziness, memory loss,...
1.1. Pharmacodynamics of the active ingredient The main active ingredient Piracetam is a manic drug that improves the metabolism of nerve cells.
1.2. Pharmacokinetics of the active substance Absorption: Oral administration of Amypira is rapidly and almost completely absorbed from the gastrointestinal tract. Bioavailability is close to 100%. Absorption does not change with long-term treatment. Distribution: volume of distribution is about 0.6l/kg. Active ingredient Piracetam penetrates all tissues and can cross the blood-brain barrier, placenta and even membranes used in renal dialysis. Piracetam is not directly bound to plasma proteins. Elimination ability: Amypira drug is excreted by the kidneys as intact, the renal clearance of piracetam in normal humans is 86ml/min. 30 hours after oral administration, more than 95% of the drug is excreted in the urine. In patients with renal impairment, the half-life is increased. 1.3. Effects of Piracetam (a cyclic derivative of gamma aminobutyric acid, GABA), which is considered a stimulant substance that is effective in improving neuronal metabolism, although not much has been known so far. study on its specific effects as well as its mechanism of action. Active ingredient Piracetam has an effect on some neurotransmitters such as acetylcholine, noradrenaline, dopamine... Amypira drug can change a neurotransmitter and contribute to improving the metabolic environment to facilitate the metabolism. nerve cells work well. In experimental studies, the active ingredient Piracetam has a protective effect against ischemic-induced metabolic disorders by enhancing the brain's resistance to oxygen deficiency. Active ingredient Piracetam increases glucose mobilization and utilization independent of oxygen supply, facilitates the Pentose pathway and maintains energy synthesis in the brain. Amypira also works to increase the release of dopamine, which has a good effect on memory formation. Active ingredient Piracetam does not have the effect of causing drowsiness, sedation, resuscitation, pain relief. The active ingredient Piracetam reduces the ability of platelets to agglomerate, and in the case of abnormally stiff red blood cells, the drug can restore red blood cells to their deformability and ability to pass through capillaries.

What does Amypira do? Amypira drug works in the treatment of the following pathologies:
Treatment of symptoms of dizziness. Treatment of post-traumatic brain injury and specific brain surgery such as psychosis, hematoma, hemiplegia and ischemia. Treatment of central nervous system disorders, specifically with symptoms of dizziness, vertigo, headache, anxiety, delirium, confusion. Treatment of memory impairment, lack of concentration, dementia in the elderly. Treatment of sickle cell anemia. Treatment of cases of acute ischemia. Alcohol addiction treatment. Treatment of sickle cell anemia. Used as adjunct in the treatment of myoclonus of cortical origin.

3.1. How to use Amypira drug is prepared in the form of an infusion and direct oral. Depending on your health condition, the doctor will consider the appropriate dose and method of taking the drug.
3.2. Dosage Amypira is used by injection or orally, divided equally 2 times a day or 3-4 times. The treating doctor usually prescribes oral medication if the patient can take it. The usual therapeutic dose is 30-160 mg/kg/day, depending on the specific indications of the treating doctor. It can also be used as an injection for oral administration if the injectable form must be discontinued. In severe cases, the dose can be increased up to 12g/day and administered intravenously.
Long-term treatment of psychosomatic syndromes in the elderly: Dosage is 1.2 - 2.4 g a day, depending on each specific case. Therapeutic doses can be as high as 4.8 g/day during the first few weeks. Treatment of alcoholism: use 12g a day during the first period of alcohol withdrawal. Cognitive impairment after brain injury (with or without dizziness): The initial therapeutic dose is 9-12 g/day; The maintenance dose is 2.4 g of the drug, taken for at least three weeks. Sickle cell anemia: The dose is 160 mg/kg/day, divided equally into 4 times. Treatment of myoclonic tremor: Active ingredient Piracetam is used at a dose of 7.2 g/day, divided into 2-3 times. Depending on response, every 3 to 4 days, increase by 4.8 g daily up to a maximum dose of 20 g/day. Once the optimal dose of Piracetam has been reached, a reduction in the therapeutic dose of concomitant drugs should be sought.

During the use of Amypira, you may appear some unwanted effects, namely restlessness, irritability, excitement, anxiety, sleep disturbances, fatigue or digestive disorders. chemical .

Amypira may interact with drugs such as CNS stimulants, psychotropic drugs or thyroid hormones.

Contraindicated to use Amypira drug in the following cases:
People with severe renal failure. Pregnant women and people who are breastfeeding. People with Huntington's disease. People with liver failure. Amypira medicine has the active ingredient Piracetam and other excipients in a sufficient amount. This is a psychotropic drug that is used to treat symptoms of dizziness, memory impairment, etc. instructions from a doctor or pharmacist.
Follow Vinmec International General Hospital website to get more health, nutrition and beauty information to protect the health of yourself and your loved ones in your family.